Publication date: Aug 01, 2025
Purpose This study aimed to evaluate the impact of COVID-19 pandemic on discrepancies between expected and actual breast cancer diagnosis. Methods Data on breast cancer incidence were obtained from the United States Cancer Statistics (USCS) program from 2001 to 2020. We compared actual breast cancer incidence rates in the year 2020 to estimated rates based on trends from 2001 to 2019. Results From 2001 to 2019, there were 4,005,763 identified cases of breast cancer in the United States. Prior to the pandemic, the incidence rate of breast cancer was 162. 87 per 100,000 in females with an annual increase of 1. 32% (p
Open Access PDF
| Concepts | Keywords |
|---|---|
| Females | breast cancer |
| Hispanic | cancer epidemiology |
| Pandemic | covid-19 |
| healthcare disparity |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| disease | MESH | Breast Cancer |
| pathway | KEGG | Breast cancer |
| disease | MESH | Cancer |
| pathway | REACTOME | Reproduction |
| drug | DRUGBANK | 2′-fluoro-5-ethylarabinosyluracil |
| disease | MESH | uncertainty |
| disease | MESH | missed diagnosis |
| disease | MESH | housing insecurities |
| disease | IDO | country |
| disease | MESH | health disparities |
| disease | MESH | myocardial infarction |
| disease | MESH | treatment delay |
| drug | DRUGBANK | Flunarizine |
| disease | MESH | death |
Original Article
(Visited 2 times, 1 visits today)